![Christopher Cain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Cain
Director/Board Member at
COGENT BIOSCIENCES, INC.
Net worth: - $ as of 2026-05-30
Profile
Christopher Cain is currently an Independent Director at Cogent Biosciences, Inc. since 2020.
Since 2024, serving as Director at Jade Biosciences, Inc. (United States).
Beginning in 2025, holds positions as Independent Director at Damora Therapeutics, Inc., Director at Viridian Therapeutics, Inc., and Independent Director at Jade Biosciences, Inc. Former roles include Vice President at Samsara BioCapital LP from 2019 to 2020 and Senior Associate at Apple Tree Venture Management LLC from 2016 to 2019.
Education includes an undergraduate degree from the University of California, Santa Barbara in 2004 and a doctorate from The University of California, San Francisco in 2010.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-08 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Christopher Cain active positions
| Companies | Position | Start |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Director/Board Member | 2020-07-05 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 2025-03-09 |
| JADE BIOSCIENCES, INC. | Director/Board Member | 2025-04-27 |
| DAMORA THERAPEUTICS, INC. | Director/Board Member | 2025-11-09 |
Former positions of Christopher Cain
| Companies | Position | End |
|---|---|---|
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 2020-01-31 |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private Equity Analyst | 2019-02-27 |
Training of Christopher Cain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
- Stock Market
- Insiders
- Christopher Cain
